Regeneron CEO Leonard Schleifer says a contract with the U.S. government signed over the summer secured roughly 300,000 doses of the company's experimental antibody cocktail.
New Episodes Streaming Sundays
Menu
You’ve reached the maximum number of streams allowed with your subscription.
To view this video, close the other videos you’re watching and try again.
Regeneron CEO Leonard Schleifer says a contract with the U.S. government signed over the summer secured roughly 300,000 doses of the company's experimental antibody cocktail.